Colon cancer patients had significantly higher TF+EMP concentrations before treatment (1655 ± 882/μl, p < 0.05) and after adjuvant chemotherapy (1149 ± 550/μl, p < 0.05) when compared to the control group (688 ± 647/μl). The gene discussed is TF; the disease is malignant colon neoplasm.